Table 1.
Significant KEGG pathways at FDR 1% and FWER of 10% (p-value cutoff = 0.1/18= 0.0056 by Bonferroni correction), identified from a postmenopausal hormone therapy proteomic study of the Women Health Initiative. P-values were calculated based on 10,000 resamplings.
Pathway names | # non-missing protein |
P-value of RHT |
P-value of SAT |
P-value of HT/GHT |
P-value of TD |
P-value of TBS |
% significant proteins* |
---|---|---|---|---|---|---|---|
Complement and coagulation cascades | 45 | 0 | 0 | 0 | 0.002 | 0 | 22.2 |
Cell communication | 12 | 0 | 0.001 | 0 | 0 | 0 | 16.7 |
Extracellular matrix receptor interaction | 12 | 0 | 0 | 0 | 0 | 0 | 16.7 |
Focal adhesion | 15 | 0 | 0 | 0 | 0 | 0 | 20.0 |
TGF-beta signaling | 7 | 0.005 | 0.003 | 0.057 | 0.072 | 0 | 0.0 |
% of proteins with significant nominal p-value at 0.10 FWER (protein p-value cutoff of 0.10/369).